210 related articles for article (PubMed ID: 28119403)
1. Are age-appropriate antibiotic formulations missing from the WHO list of essential medicines for children? A comparison study.
Ivanovska V; Leufkens HG; Rademaker CM; Zisovska E; Pijnenburg MW; van Dijk L; Mantel-Teeuwisse AK
Arch Dis Child; 2017 Apr; 102(4):352-356. PubMed ID: 28119403
[TBL] [Abstract][Full Text] [Related]
2. WHO essential medicines for children 2011-2019: age-appropriateness of enteral formulations.
Orubu ESF; Duncan J; Tuleu C; Turner MA; Nunn A
Arch Dis Child; 2022 Apr; 107(4):317-322. PubMed ID: 34479858
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool.
Walsh J; Masini T; Huttner BD; Moja L; Penazzato M; Cappello B
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335850
[TBL] [Abstract][Full Text] [Related]
4. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.
Hsia Y; Sharland M; Jackson C; Wong ICK; Magrini N; Bielicki JA
Lancet Infect Dis; 2019 Jan; 19(1):67-75. PubMed ID: 30522834
[TBL] [Abstract][Full Text] [Related]
5. Essential medicines for children in Armenia.
Kazaryan I; Vardanyan L
Int J Risk Saf Med; 2015; 27 Suppl 1():S43-4. PubMed ID: 26639704
[TBL] [Abstract][Full Text] [Related]
6. Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development.
Orubu ES; Okwelogu C; Opanuga O; Nunn T; Tuleu C
Health Policy Plan; 2017 Mar; 32(2):225-235. PubMed ID: 28207051
[TBL] [Abstract][Full Text] [Related]
7. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
[TBL] [Abstract][Full Text] [Related]
8. A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename).
Coelho HL; Rey LC; Medeiros MS; Barbosa RA; Cruz Fonseca SG; Costa PQ
J Pediatr (Rio J); 2013; 89(2):171-8. PubMed ID: 23642428
[TBL] [Abstract][Full Text] [Related]
9. Global sales of oral antibiotics formulated for children.
Li G; Jackson C; Bielicki J; Ellis S; Hsia Y; Sharland M
Bull World Health Organ; 2020 Jul; 98(7):458-466. PubMed ID: 32742031
[TBL] [Abstract][Full Text] [Related]
10. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
Freerks L; Sommerfeldt J; Löper PC; Klein S
Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
[TBL] [Abstract][Full Text] [Related]
11. Availability of Pediatric Formulations in Public Health Care System in India: A Case Study.
Roy V; Singhal S; Tayal H; Dubey AP
Indian J Pediatr; 2021 Mar; 88(3):227-234. PubMed ID: 32086758
[TBL] [Abstract][Full Text] [Related]
12. Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review.
Rashed AN; Jackson C; Gastine S; Hsia Y; Bielicki J; Standing JF; Tomlin S; Sharland M
Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1099-1106. PubMed ID: 31760892
[No Abstract] [Full Text] [Related]
13. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
[TBL] [Abstract][Full Text] [Related]
14. High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries.
Bortone B; Jackson C; Hsia Y; Bielicki J; Magrini N; Sharland M
PLoS One; 2021; 16(1):e0241899. PubMed ID: 33471786
[TBL] [Abstract][Full Text] [Related]
15. Access to essential anticancer medicines for children and adolescents in Europe.
Vassal G; Kozhaeva O; Griskjane S; Arnold F; Nysom K; Basset L; Kameric L; Kienesberger A; Kamal S; Cherny N; Bricalli G; Latino N; Kearns P
Ann Oncol; 2021 Apr; 32(4):560-568. PubMed ID: 33388384
[TBL] [Abstract][Full Text] [Related]
16. Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project.
Barbieri E; Minotti C; Cavagnis S; Giaquinto C; Cappello B; Penazzato M; Lallemant M
Front Pharmacol; 2023; 14():1200848. PubMed ID: 37529704
[TBL] [Abstract][Full Text] [Related]
17. Essential and forgotten antibiotics: An inventory in low- and middle-income countries.
Tebano G; Li G; Beovic B; Bielicki J; Brink A; Enani MA; Godman B; Hinrichsen SL; Kibuule D; Gabriel LH; Oduyebo O; Sharland M; Singh S; Wertheim HFL; Nathwani D; Pulcini C;
Int J Antimicrob Agents; 2019 Sep; 54(3):273-282. PubMed ID: 31260741
[TBL] [Abstract][Full Text] [Related]
18. Availability of pediatric-evaluated formulations in Serbia.
Božić B; Stupar S; Stupar D; Babić U; Bajčetić M
Indian J Pharmacol; 2017; 49(2):189-193. PubMed ID: 28706333
[TBL] [Abstract][Full Text] [Related]
19. Pediatric drug formulations: a review of challenges and progress.
Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
[TBL] [Abstract][Full Text] [Related]
20. Essential medicines availability is still suboptimal in many countries: a scoping review.
Mahmić-Kaknjo M; Jeličić-Kadić A; Utrobičić A; Chan K; Bero L; Marušić A
J Clin Epidemiol; 2018 Jun; 98():41-52. PubMed ID: 29452222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
